<code id='E472051894'></code><style id='E472051894'></style>

<acronym id='E472051894'></acronym>

<center id='E472051894'><center id='E472051894'><tfoot id='E472051894'></tfoot></center><abbr id='E472051894'><dir id='E472051894'><tfoot id='E472051894'></tfoot><noframes id='E472051894'>

<optgroup id='E472051894'><strike id='E472051894'><sup id='E472051894'></sup></strike><code id='E472051894'></code></optgroup>

<b id='E472051894'><label id='E472051894'><select id='E472051894'><dt id='E472051894'><span id='E472051894'></span></dt></select></label></b><u id='E472051894'></u>

~~<i id='E472051894'><strike id='E472051894'><tt id='E472051894'><pre id='E472051894'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

hotspot

author：Wikipedia 2025-10-06 16:43:13 Page View：5976

Adam's take main illustration — Molly Ferguson/STAT

Biotech is awash in PIPEs.

The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

advertisement

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Megan Rapinoe shares emotional post following US Women's World Cup exit
Next article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban

focus

Peter Hotez and the public health issue of online harassment

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

For longer

For longer

MarianF.MoratinosforSTATEnticedbytheimmensemarketopenedbyGLP-1weightlossdrugsWegovyandZepbound,ahand

Medicare proposal to cover medical devices draws a mixed reaction

Medicare proposal to cover medical devices draws a mixed reaction

AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

CytokineticsCEORobertBlumspokelastweekatatalkduringSTAT’sBreakthroughSummitWestinSanFrancisco.SarahG

read more